title: [Mixed cryoglobulinemia in hepatitis C virus infection. Value of interferon therapy].
authors.forename: B
authors.initials: B
authors.lastname: Taillan
authors.forename: P
authors.initials: P
authors.lastname: Ferrari
authors.forename: J G
authors.initials: JG
authors.lastname: Fuzibet
authors.forename: E
authors.initials: E
authors.lastname: Ferrari
authors.forename: J F
authors.initials: JF
authors.lastname: Quaranta
authors.forename: P
authors.initials: P
authors.lastname: Dujardin
mesh_terms: D003449:Cryoglobulinemia / Q000209:etiology* / Q000628:therapy; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D011994:Recombinant Proteins
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins
vernacular_title: Cryoglobulinémie mixte au cours de l'infection par le virus de l'hépatite C. Intérêt de l'interféron.